Latin America Neglected Tropical Disease Treatment Market Size & Outlook
Related Markets
Latin America neglected tropical disease treatment market highlights
- The Latin America neglected tropical disease treatment market generated a revenue of USD 1,128.0 million in 2024.
- The market is expected to grow at a CAGR of 5.6% from 2025 to 2033.
- In terms of segment, dengue was the largest revenue generating disease in 2024.
- Dengue is the most lucrative disease segment registering the fastest growth during the forecast period.
Latin America data book summary
| Market revenue in 2024 | USD 1,128.0 million |
| Market revenue in 2033 | USD 1,850.3 million |
| Growth rate | 5.6% (CAGR from 2025 to 2033) |
| Largest segment | Dengue |
| Fastest growing segment | Dengue |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dengue |
| Key market players worldwide | F. Hoffmann-La Roche AG, Bayer AG, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc, Eisai Co Ltd, Sanofi SA, Astellas Pharma Inc, Takeda Pharmaceutical Co Ltd, Gilead Sciences Inc |
Other key industry trends
- In terms of revenue, Latin America region accounted for 28.5% of the global neglected tropical disease treatment market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
- Latin America is the fastest growing regional market and is projected to reach USD 1,850.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neglected Tropical Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| F. Hoffmann-La Roche AG | View profile | - | - | - |
| GlaxoSmithKline PLC | View profile | - | - | - |
| Novartis AG | View profile | - | - | - |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Eisai Co Ltd | View profile | 11076 | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan, 112-8088 | http://www.eisai.co.jp |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| Gilead Sciences Inc | View profile | 18000 | 333 Lakeside Drive, Foster, CA, United States, 94404 | https://www.gilead.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
Latin America neglected tropical disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical disease treatment market will help companies and investors design strategic landscapes.
Dengue was the largest segment with a revenue share of 105.68% in 2024. Horizon Databook has segmented the Latin America neglected tropical disease treatment market based on dengue covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Latin America neglected tropical disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America neglected tropical disease treatment market databook
-
Our clientele includes a mix of neglected tropical disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America neglected tropical disease treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America neglected tropical disease treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
